Physician profile
Stephen Soong
NPI 1194017863
$2,146.83
in general payments reported to CMS, 2019-2025
22 companies · $432 in 2025
The $432 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $156 · 2021: $331 · 2022: $508 · 2023: $149 · 2024: $319 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $412.59 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $287.29 | 2022-2025 | Botox |
| Medtronic, INC. | $218.21 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Allergan, INC. | $182.64 | 2019-2021 | |
| Spr Therapeutics, INC | $148.67 | 2019-2025 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $95.76 | 2025 | |
| Collegium Pharmaceutical, INC. | $92.94 | 2021-2024 | Belbuca |
| Averitas Pharma INC. | $88.88 | 2024-2025 | Qutenza |
| Abbott Laboratories | $81.40 | 2019-2025 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.39 | 2019-2022 | |
| Globus Medical, INC. | $77.84 | 2025 | Senza |
| Pfizer INC. | $77.41 | 2020-2021 | |
| Nevro Corp. | $74.31 | 2022-2024 | Senza |
| Forte Bio-Pharma LLC | $57.61 | 2020-2021 | |
| Mdd US Operations, LLC | $39.74 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $38.52 | 2024 | Generator |
| Ibsa Pharma INC. | $20.49 | 2023 | Tirosint, Licart |
| Medtronic USA, INC. | $16.67 | 2019 | |
| Biodelivery Sciences International, INC. | $15.90 | 2020 | |
| Sentynl Therapeutics, INC. | $13.81 | 2019 | |
| Virtus Pharmaceuticals LLC | $12.51 | 2021 | |
| Lilly USA, LLC | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Soong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.